Loading...
Senior International Marketing Manager & Commercial Operations, Menstrual Migraine at Abbvie
AbbvieMettawa, IL, us·6h ago
SeniorFull-time
Salary Range
$88,400 - $119,600 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
The Marketing Manager serves as a strategic cross-functional leader focused on Menstrual Migraine. This role is responsible for developing innovative marketing strategies and communications, while maintaining alignment with broader brand and organizational objectives.
Key Responsibilities
- →Lead strategic development and execution of marketing initiatives for Menstrual Migraine, ensuring integration with the overall migraine portfolio direction.
- →Analyze data from market research, performance dashboards, and Veeva reports to generate actionable insights for Menstrual Migraine and inform portfolio strategy alignment.
- →Collaborate with cross-functional stakeholders including Market Access, Medical Affairs, Regulatory, Legal, Public Affairs, Health Economics, Patient Relations, Business Insights, OEC, and Global Learning.
- →Influence without authority in a matrix setting, demonstrating strong cross-functional leadership to align Menstrual Migraine tactics with strategic imperatives.
- →Identify performance gaps within Menstrual Migraine, working with Areas/affiliates to co-create corrective actions.
- →Support launch readiness and continuous execution for Menstrual Migraine, communicating proactively around key initiatives.
- →Manage external relationships with vendors, agencies, and Key Opinion Leaders to maximize impact and efficiency.
Requirements
- ✓Proven experience in strategic marketing, preferably in healthcare or pharmaceutical industry.
- ✓Strong analytical skills with experience in market research and data analysis.
- ✓Excellent cross-functional collaboration and leadership abilities.
- ✓Experience in managing external relationships and stakeholder alignment.
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
